Mike Sathekge is a Professor and Head of Nuclear Medicine department at University of Pretoria and Steve Biko Academic Hospital. He also heads the South African Nuclear Medicine …

Nuclear Medicine and Biology (WFNMB). Sathekge is Chairman of the Medical Research Council of South Africa. He has performed several first-in-human studies and introduced peptide rece.

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177 Lu]Lu-PSMA-617. A WARMTH … H Ahmadzadehfar, K …

Mike SATHEKGE, Head of Department | Cited by 5,619 | of University of Pretoria, Pretoria (UP) | Read 336 publications | Contact Mike SATHEKGE

We aimed to report the safety and antitumour activity of 225 Ac-PSMA RLT of mCRPC in a large cohort of patients treated at multiple centres across the world. Methods: This retrospective …

2021年3月5日 · Head of Nuclear Medicine at the University of Pretoria (UP) and at the Steve Biko Academic Hospital (SBAH) Professor Mike Sathekge was awarded the Presidential Award at …

Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy? [68 Ga]Ga-FAPI versus [18F]F-FDG in malignant melanoma: …

Machaba Michael Sathekge is a Professor and Head of the Department of Nuclear Medicine at the University of Pretoria (UP) and Steve Biko Academic Hospital (SBAH). He is Head of the …

2023年7月20日 · The Society of Nuclear Medicine and Molecular Imaging (SNMMI), the leading international nuclear medicine congress, has bestowed one of its highest honours upon …

2017年8月15日 · Prof Mike Sathekge, an internationally acclaimed researcher and current Head of the Department of Nuclear Medicine in the Faculty of Health Sciences at the University of …